These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2111611)

  • 1. [Intravenous immunoglobulin in the treatment of malignant epilepsy in children].
    Sterio M; Gebauer E; Vucicević G; Zalisevskij G; Felle D; Kolarov N
    Wien Klin Wochenschr; 1990 Apr; 102(8):230-3. PubMed ID: 2111611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Malignant epilepsy in children: therapy with high doses of intravenous immunoglobulin].
    Sterio M; Gebauer E; Felle D; Vucicević G; Zalisevskij G
    Med Pregl; 1992; 45(5-6):220-4. PubMed ID: 1365062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3 case reports of patients with malignant epilepsy treated with high doses of intravenous immunoglobulin].
    Sterio M; Gebauer E; Vucićević G; Zalisevskij G; Felle D; Kolarov N
    Med Pregl; 1989; 42(9-10):332-4. PubMed ID: 2636331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG2 deficiency and intractable epilepsy of childhood.
    Duse M; Tiberti S; Plebani A; Avanzini MA; Gardenghi M; Menegati E; Monafo V; Ugazio AG
    Monogr Allergy; 1986; 20():128-34. PubMed ID: 3773903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High-dose immunoglobulin treatment of epilepsy in children].
    Voit T
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():146-8; discussion 149. PubMed ID: 8499745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravenous treatment with immunoglobulins in epileptic syndromes which are difficult to control].
    Espinosa Zacarías J; Gutiérrez Moctezuma J; Villegas Peña H; Olmos G De Alba G
    Rev Neurol; 2002 May 1-15; 34(9):816-9. PubMed ID: 12134341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous gamma-globulin therapy and serum IgG subclass levels in intractable childhood epilepsy.
    Plebani A; Duse M; Tiberti S; Avanzini MA; Monafo V; Menegati E; Ugazio AG; Burgio GR
    Monogr Allergy; 1988; 23():204-15. PubMed ID: 2455220
    [No Abstract]   [Full Text] [Related]  

  • 8. [Personal experience in the treatment of malignant epilepsies in children using high doses of intravenous immunoglobulins].
    Sterio M; Gebauer E; Fellé D; Vucićević G
    Med Pregl; 1988; 41(7-8):305-8. PubMed ID: 3150032
    [No Abstract]   [Full Text] [Related]  

  • 9. [Personal experience in the immunomodulation of immunothrombocytopenic purpura in children using high doses of i.v. immunoglobulin].
    Gebauer E; Tomić J; Felle D
    Med Pregl; 1991; 44(1-2):26-9. PubMed ID: 1908043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG subclasses in epileptic children.
    Oguro N; Miyao M; Shimoizumi H; Kobayashi S; Momoi M; Yanagisawa M
    Jpn J Psychiatry Neurol; 1990 Jun; 44(2):420-1. PubMed ID: 2259037
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum IgG subclass deficiency in ataxia-telangiectasia.
    Aucouturier P; Bremard-Oury C; Griscelli C; Berthier M; Preud'homme JL
    Clin Exp Immunol; 1987 May; 68(2):392-6. PubMed ID: 3652519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [IgG subclass deficiency in childhood. Changes in the antigen specific immune response and significance of low IgG4 level].
    Bartmann P; Fleischer S; Wagner H; Kleihauer E
    Monatsschr Kinderheilkd; 1988 Jan; 136(1):31-7. PubMed ID: 2451127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of IgG subclass deficiency with the initial presentation of transient hypogammaimmuno-globulinemia of infancy and a review of IgG subclass deficiencies.
    Nettagul R; Visitsunthorn N; Vichyanond P
    J Med Assoc Thai; 2003 Jul; 86(7):686-92. PubMed ID: 12948264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyridoxal phosphate is better than pyridoxine for controlling idiopathic intractable epilepsy.
    Wang HS; Kuo MF; Chou ML; Hung PC; Lin KL; Hsieh MY; Chang MY
    Arch Dis Child; 2005 May; 90(5):512-5. PubMed ID: 15851435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin treatment of patients with selective IgG subclass and IgA deficiency states.
    Björkander J; Oxelius VA; Söderström R; Hanson LA
    Monogr Allergy; 1988; 23():160-7. PubMed ID: 3386638
    [No Abstract]   [Full Text] [Related]  

  • 16. IgG replacement therapy in IgG subclass-deficient children.
    Beard LJ; Ferrante A
    Monogr Allergy; 1988; 23():194-203. PubMed ID: 3386641
    [No Abstract]   [Full Text] [Related]  

  • 17. Increases in serum immunoglobulins to age-related normal levels in children with IgA and/or IgG subclass deficiency.
    Kutukculer N; Karaca NE; Demircioglu O; Aksu G
    Pediatr Allergy Immunol; 2007 Mar; 18(2):167-73. PubMed ID: 17338791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune globulin treatment in intractable epilepsy of childhood.
    Türkay S; Baskin E; Dener S; Gültekin A; Tanzer F; Sekreter E
    Turk J Pediatr; 1996; 38(3):301-5. PubMed ID: 8827898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical relevance of immunoglobulin subclasses in children with chronic pulmonary diseases].
    Zielen S; Wönne R; Gerein V; Kotitschke R; Zeidler R; Hofmann D
    Monatsschr Kinderheilkd; 1987 Nov; 135(11):775-9. PubMed ID: 3431558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonpharmacologic treatment of the catastrophic epilepsies of childhood.
    Wheless JW
    Epilepsia; 2004; 45 Suppl 5():17-22. PubMed ID: 15283707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.